|Bid||0.0650 x 0|
|Ask||0.0700 x 0|
|Day's Range||0.0550 - 0.0700|
|52 Week Range||0.0350 - 0.1200|
|Beta (5Y Monthly)||0.86|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jan. 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Sproutly Announces Submission of NNCP Notification with Health Canada for Sale of Cannabis-Infused Beverages
Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) ("Sproutly" or the "Company") announces that the Company has entered into a fourth supplemental indenture dated April 22, 2021 (the "Fourth Supplemental Indenture") between the Company and TSX Trust Company, as trustee, which amends the terms of its convertible debenture indenture dated October 24, 2018 (the "Original Indenture"), as amended by the first supplemental indenture dated April 24, 2020 (the "First Supplemental Indenture") and as further amended by the second supplemental indenture dated July 23, 2020 (the "Second Supplemental Indenture") and as further amended by the third supplemental indenture dated September 23, 2020 (the "Third Supplemental Indenture", and together with the Original Indenture, the First Supplemental Indenture and the Second Supplemental Indenture, the "Indenture") providing for the issuance of 8.0% senior unsecured convertible debentures in the aggregate principal amount of $10,750,000 (the "Debentures").
Sproutly Canada, Inc. (CSE:SPR) (OTCQB:SRUTF) (FSE:38G) ("Sproutly" or the "Company"), is pleased to announce it has executed the definitive agreement (the "Agreement") with CannaHive Inc. ("CannaHive"), consistent with the revised letter of intent that was announced in February of this year. This agreement finalizes the commercial arrangement with CannaHive to produce Cannabis 2.0 products at the Company’s subsidiary, Toronto Herbal Remedies’ ("THR"), licensed facility.